- Home
- North America At Home Testing Kits Market

North America At-Home Testing Kits Market - Industry Trends and Forecast to 2028
- Published Date: September, 2022 | Report ID: CLS-67 | No of pages: 130 | Format:
North America at-home testing kits market is projected to register a CAGR of 5.5% in the forecast period of 2021 to 2028. The new market report contains data for historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.
Market Segmentation:
North America At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit and Other Test Types), Type (Cassette, Strip, Midstream, Test Panel, Dip Card and Other Form Types), Age (Pediatric, Adult and Geriatric), Sample Type (Urine, Blood, Saliva and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028
Some of the major factors contributing to the growth of the North America at-home testing kits market are:
Low costs and easy availability of various self-test kits at pharmacies
Growing adoption of self-test kits due to increased importance of HIV diagnostics
Market Players
Some of the major players operating in the North America at-home testing kits market are:
Abbott
ACON Laboratories, Inc.
Rapikit
BTNX INC.
bioLytical Laboratories Inc.
OraSure Technologies, Inc.
Cardinal Health
BD
B. Braun Melsungen AG
Piramal Enterprises Ltd.
Siemens Healthcare GmbH
Quidel Corporation
Bionime Corporation
SA Scientific
ARKRAY USA, Inc.
Everlywell, Inc.
Nova Biomedical
Eurofins Viracor, Inc. (a subsidiary of Eurofins Scientific)
AdvaCare Pharma
Atlas Medical UK
TaiDoc Technology Corporation
LifeScan IP Holdings, LLC
Chembio Diagnostics, Inc.
Drgerwerk AG & Co. KGaA
F. Hoffmann-La Roche Ltd
Sensing Self, PTE. Ltd
RUNBIO BIOTECH CO.,LTD.
Clearblue (a subsidiary of CLEAR BLUE TECHNOLOGIES INC.)
Mylan N.V. (a subsidiary of Viatris, Inc.)
MP BIOMEDICALS
VedaLab
Ascensia Diabetes Care Holdings AG
TABLE OF CONTENT
Segmentation
Short Description
North America At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit and Other Test Types), Type (Cassette, Strip, Midstream, Test Panel, Dip Card and Other Form Types), Age (Pediatric, Adult and Geriatric), Sample Type (Urine, Blood, Saliva and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028
Market Definition
At-home testing kits means testing instruments which help person to perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at very affordable rate. Self-tests are usually the advance versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by common person.
Market Segmentation
The at-home testing kits market is segmented on the basis of test type, type, age, sample type, usage and distribution channels.
On the basis of test type, the at-home testing kits market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit and other test types
On the basis of type, the at-home testing kits market is segmented into cassette, strip, midstream, test panel, dip card and other form types
On the basis of age, the at-home testing kits market is segmented into pediatric, adult and geriatric
On the basis of sample type, the at-home testing kits market has been segmented into urine, blood, saliva and other sample types
On the basis of usage, the at-home testing kits market is segmented into disposable and reusable
On the basis of distribution channels, the at-home testing kits market is segmented into retail pharmacies, drug store, supermarket/hypermarket and online pharmacies
Market Players
Some of the major players operating in the North America at-home testing kits market are:
Abbott
ACON Laboratories, Inc.
Rapikit
BTNX INC.
bioLytical Laboratories Inc.
OraSure Technologies, Inc.
Cardinal Health
BD
B. Braun Melsungen AG
Piramal Enterprises Ltd.
Siemens Healthcare GmbH
Quidel Corporation
Bionime Corporation
SA Scientific
ARKRAY USA, Inc.
Everlywell, Inc.
Nova Biomedical
Eurofins Viracor, Inc. (a subsidiary of Eurofins Scientific)
AdvaCare Pharma
Atlas Medical UK
TaiDoc Technology Corporation
LifeScan IP Holdings, LLC
Chembio Diagnostics, Inc.
Drgerwerk AG & Co. KGaA
F. Hoffmann-La Roche Ltd
Sensing Self, PTE. Ltd
RUNBIO BIOTECH CO.,LTD.
Clearblue (a subsidiary of CLEAR BLUE TECHNOLOGIES INC.)
Mylan N.V. (a subsidiary of Viatris, Inc.)
MP BIOMEDICALS
VedaLab
Ascensia Diabetes Care Holdings AG
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.